Assessing eligibility for differentiated service delivery, HIV services utilization and virologic outcomes of adult HIV-infected patients in Sierra Leone: a pre-implementation analysis

References

• Joint United Nations Programme on HIV/AIDS. UNAIDS data 2020. Geneva: Joint United Nations Programme on HIV/AIDS; 2020 [ cited 2021 May 17]. Available from: https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-book_en.pdf
   Google Scholar
• World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2nd edition. Geneva: World Health Organization; 2016. [ cited 2021 May 17]. Available from]: https://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf?sequence=1
   Google Scholar
• Department of Health and Human Services. Adult and adolescent guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Geneva: Department of Health and Human Services; 2019 [ cited 2021 May 17]. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf
   Google Scholar
• European AIDS Clinical Society. Guidelines version 10.0. European AIDS Clinical Society; 2019 [ cited 2021 May 17]. Available from: https://www.eacsociety.org/files/2019_guidelines-10.0_final.pdf
   Google Scholar
• International AIDS Society. Differentiated care for HIV: a decision framework for antiretroviral therapy delivery. International AIDS Society; 2018 [ cited 2021 May 7]. Available from: http://www.differentiatedcare.org/Portals/0/adam/Content/yS6M-GKB5EWs_uTBHk1C1Q/File/Decision%20Framework.pdf
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. Regional Factsheets-West and Central Africa. Geneva: Joint United Nations Programme on HIV/AIDS; 2018 [ cited 2021 May 17]. Available from: https://www.unaids.org/en/regionscountries/westandcentralafrica
   Google Scholar
• International AIDS Society. Prioritizing differentiated ART delivery to fast track reaching HIV targets in West and Central Africa. International AIDS Society; 2017 [ cited 2021 May 17]. Available from: http://www.differentiatedcare.org/Portals/0/adam/Content/6Byqnat6lk-IGpSg9Juhxw/File/4%20pager%20English%20WEB.pdf
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. UNAIDS data 2019. Geneva: Joint United Nations Programme on HIV/AIDS; 2019 [ cited 2021 May 17]. Available from: https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf
   Google Scholar
• Yendewa GA, Poveda E, Yendewa SA, et al. HIV/AIDS in Sierra Leone: characterizing the hidden epidemic. AIDS Rev. 2018;20:104–10.
   Web of Science ®Google Scholar
• Yendewa GA, Poveda E, Lakoh S, et al. High prevalence of late-stage disease in newly diagnosed human immunodeficiency virus patients in Sierra Leone. Open Forum Infect Dis. 2018;5:ofy208.
   Web of Science ®Google Scholar
• Lakoh S, Jiba DF, Kanu JE, et al. Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study. BMC Public Health. 2019;19:1320.
   PubMed Web of Science ®Google Scholar
• Yendewa GA, Sahr F, Lakoh S, et al. Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone. J Antimicrob Chemother. 2019;74:2024–2029.
   Web of Science ®Google Scholar
• International AIDS Society. Guide of differentiated care models in Sierra Leone. International AIDS Society; 2018 [ cited 2021 May 17]. Available from: https://www.differentiatedcare.org/Portals/0/adam/Content/AINWnDOUcEKx_l__ltN5LQ/File/Guide%20of%20Differentiated%20%20care%20Model%20Sierra%20Leone%20-%20Final%20Version%20May%202018.pdf
   Google Scholar
• Wilkinson L, Grimsrud A. The time is now: expedited HIV differentiated service delivery during the COVID-19 pandemic. J Int AIDS Soc. 2020;23:e25503.
   PubMed Web of Science ®Google Scholar
• The Global Fund to Fight HIV, TB and Malaria. COVID‐19 information note: considerations for global fund HIV support. The Global Fund to Fight HIV, TB and Malaria; 2020 [ cited 2021 May 18]. Available from: https://www.theglobalfund.org/media/9512/covid19_hiv_infonote_en.pdf
   Google Scholar
• Vandy AO Prioritized DSD implementation in Sierra Leone due to COVID-19 [ cited 2021 May 18]. Available from: https://www.differentiatedcare.org/Portals/0/adam/Content/qcqYrwZXBkuwJi-toy0O8w/File/6%20DSD%20in%202020_Vandy_pdf.pdf
   Google Scholar
• Songo IDM Utilizing the network of HIV positives in Sierra Leone (NETHIPS) for DSD during COVID-19 [ cited 2021 May 18]. Available from: https://www.differentiatedcare.org/Portals/0/adam/Content/fXkJUUeS8EyazJsy1IMMow/File/5%20DSD%20in%202020_Songo_pdf.pdf
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. Rights in the time of COVID‐19: lessons from HIV for an effective, community‐led response. Geneva: Joint United Nations Programme on HIV/AIDS; 2020 [ cited 2021 May 18]. Available from: https://www.unaids.org/sites/default/files/media_asset/human-rights-and-covid-19_en.pdf
   Google Scholar
• Hoffman RM, Balakasi K, Bardon AR, et al. Eligibility for differentiated models of HIV treatment service delivery: an estimate from Malawi and Zambia. AIDS. 2020;34:475–479.
   Web of Science ®Google Scholar
• World Health Organization‎. WHO consultation on technical and operational recommendations for scale-up of laboratory services and monitoring HIV antiretroviral therapy in resource-limited settings. Geneva: World Health Organization; 2005 [ cited 2021 May 18]. Available from: https://apps.who.int/iris/handle/10665/43344
   Google Scholar
• Roberts T, Cohn J, Bonner K, et al. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62:1043–1048.
   PubMed Web of Science ®Google Scholar
• Alemnji G, Fonjungo P, Van Der Pol B, et al. The centrality of laboratory services in the HIV treatment and prevention cascade: the need for effective linkages and referrals in resource-limited settings. AIDS Patient Care STDS. 2014;28:268–273.
   Web of Science ®Google Scholar
• Kelly JD, Reid MJ, Lahiff M, et al. Community-level HIV stigma as a driver for HIV transmission risk behaviors and sexually transmitted diseases in Sierra Leone: a population-based study. J Acquir Immune Defic Syndr. 2017;75:399–407.
   PubMed Web of Science ®Google Scholar
• Kelly JD, Weiser SD, Tsai AC. Proximate context of HIV stigma and its association with HIV testing in Sierra Leone: a population-based study. AIDS Behav. 2016;20:65–70.
   PubMed Web of Science ®Google Scholar
• Lahai M, James PB, Wannang NN, et al. A cross-sectional study on caregivers’ perspective of the quality of life and adherence of paediatric HIV patients to highly active antiretroviral therapy. BMC Pediatr. 2020;20:286.
   Web of Science ®Google Scholar
• Nachega JB, Marconi VC, Van Zyl GU, et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011;11:167–174.
   PubMedGoogle Scholar
• Taieb F, Madec Y, Cournil A, et al. Virological success after 12 and 24 months of antiretroviral therapy in sub-Saharan Africa: comparing results of trials, cohorts and cross-sectional studies using a systematic review and meta-analysis. PLoS One. 2017;12:e0174767.
   Web of Science ®Google Scholar
• Anude CJ, Eze E, Onyegbutulem HC, et al. Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. BMC Infect Dis. 2013;13:113.
   PubMed Web of Science ®Google Scholar
• Obiri-Yeboah D, Pappoe F, Baidoo I, et al. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana. BMC Infect Dis. 2018;18:230.
   Web of Science ®Google Scholar
• Meloni ST, Chang CA, Eisen G, et al. Long-term outcomes on antiretroviral therapy in a large scale-up program in Nigeria. PLoS One. 2016;11:e0164030.
   Web of Science ®Google Scholar
• World Health Organization. HIV drug resistance report 2019. Geneva: World Health Organization; 2019 [ cited 2021 May 18]. Available from: https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en/
   Google Scholar
• World Health Organization. Global action plan on HIV drug resistance (2017-2021). Geneva: World Health Organization; 2017 [ cited 2021 May 18]. Available from: https://apps.who.int/iris/bitstream/handle/10665/255883/9789241512848-eng.pdf?sequence=1
   Google Scholar